DPHARMA

1.180

-0.01 (-0.8%)

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2021

DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2021
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2021
The figures have not been audited

Attachments

Duopharma Biotech - Financial Report Q3 2021.pdf
248.7 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2021

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2021
30 Sep 2020
30 Sep 2021
30 Sep 2020
$$'000
$$'000
$$'000
$$'000
1 Revenue
171,838
133,772
493,731
435,816
2 Profit/(loss) before tax
22,483
18,568
65,856
55,686
3 Profit/(loss) for the period
16,963
14,127
49,967
42,417
4 Profit/(loss) attributable to ordinary equity holders of the parent
16,963
14,127
49,967
42,417
5 Basic earnings/(loss) per share (Subunit)
1.80
1.52
5.31
4.59
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.50
0.50


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
 Net assets per share attributable to ordinary equity holders of the parent ($$)
0.6500
0.7000

Remarks : 
Pursuant to MFRS 133 Earnings Per Share, the Earnings Per Share for the corresponding quarter and year to date ended 30 September 2020 had been retrospectively adjusted to reflect the effect of the bonus shares allotted on 7 September 2021.

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence


Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 18 Nov 2021
Category Financial Results
Reference Number FRA-07112021-00002


View original announcement